Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al

Arthritis Rheum. 2003 Jan;48(1):269-70. doi: 10.1002/art.10629.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / pathology
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunosuppressive Agents / adverse effects*
  • Middle Aged
  • Paraplegia / chemically induced*
  • Paraplegia / pathology
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept